Covered recipient · General Payments record
MARK FERGESON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$774.81
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $580.68 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.29 | 19 |
| Supernus Pharmaceuticals, Inc. | $142.29 | 2 |
| Astellas Pharma US Inc | $130.16 | 3 |
| Janssen Pharmaceuticals, Inc | $102.53 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.72 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $21.45 | 1 |
| Amgen Inc. | $14.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3.44 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097834 | CMS |
| ABBVIE INC. | $5.17 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097836 | CMS |
| ABBVIE INC. | $7.98 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097838 | CMS |
| ABBVIE INC. | $7.35 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097840 | CMS |
| ABBVIE INC. | $9.65 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097842 | CMS |
| ABBVIE INC. | $5.99 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097844 | CMS |
| ABBVIE INC. | $4.03 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097846 | CMS |
| ABBVIE INC. | $7.16 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097848 | CMS |
| ABBVIE INC. | $3.21 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097850 | CMS |
| ABBVIE INC. | $8.29 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097852 | CMS |
| ABBVIE INC. | $3.40 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097854 | CMS |
| ABBVIE INC. | $7.88 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097856 | CMS |
| ABBVIE INC. | $7.52 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097858 | CMS |
| ABBVIE INC. | $13.81 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097860 | CMS |
| ABBVIE INC. | $7.41 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097862 | CMS |
| ABBVIE INC. | $4.87 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097864 | CMS |
| ABBVIE INC. | $30.80 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097866 | CMS |
| ABBVIE INC. | $4.18 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097868 | CMS |
| ABBVIE INC. | $6.15 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107097870 | CMS |
| Amgen Inc. | $14.24 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117552637 | CMS |
| Astellas Pharma US Inc | $13.45 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139477004 | CMS |
| Astellas Pharma US Inc | $97.77 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139525548 | CMS |
| Astellas Pharma US Inc | $18.94 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139472020 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $21.45 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146772858 | CMS |
| Janssen Pharmaceuticals, Inc | $102.53 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078140805 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.72 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119069976 | CMS |
| Supernus Pharmaceuticals, Inc. | $24.97 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147867646 | CMS |
| Supernus Pharmaceuticals, Inc. | $117.32 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147867648 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.